NFKB1 and colitis: LA, 20–80 mg/kg, inhibited NF-κB signaling during treatment of acute inflammation in various mouse models, such as LPS-induced acute lung injury (Chu et al., 2012; Liu et al., 2019), LPS-induced acute kidney injury (Hu and Liu, 2016), and DSS-induced colitis (Liu et al., 2018).